BioMedNewsBreaks – InnerScope Hearing Technologies Inc. (INND) to Present at Diamond Equity Research Emerging Growth Virtual Conference

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the direct-to-consumer (“DTC”) hearing technology space, today announced that its CEO Matthew Moore was invited to present at the Diamond Equity Research Emerging Growth Invitation Virtual Conference. InnerScope will be the only OTC: Pink company invited to present alongside NASDAQ-listed companies for the May 11, 2021, virtual conference. Moore is scheduled to host a virtual presentation to institutional investors at 12:20 p.m. ET, during which he will provide an overview of InnerScope’s business as a disruptive leader in the emerging DTC hearing aid device market, expected to be worth tens of billions of dollars. Moore will highlight recent corporate achievements in providing easy, convenient and affordable access to its DTC app-controlled technology for the 48 million Americans with hearing loss. Interested parties should visit https://ibn.fm/5sGdD to register for and access the live presentation.

To view the full press release, visit https://ibn.fm/W4tvP

About InnerScope Hearing Technologies Inc.

InnerScope Hearing Technologies is a manufacturer, distributor and retailer of FDA-Registered direct-to-consumer (“DTC”) app-controlled, self-adjusting hearing aids and personal sound amplifier products, doctor-formulated dietary hearing & tinnitus supplements, and assorted ear & hearing health-related products (collectively “hearing products”). Its mission is to improve the quality of life of the 70 million people in North America who suffer from hearing impairment and/or hearing-related issues. The management team of InnerScope is applying decades of industry experience and believes it is well positioned to directly benefit from the Over-the-Counter Hearing Aid Act (expected to be enacted within the next few months). InnerScope offers affordable app-controlled, self-adjusting hearing technology (www.NoHassleHearing.com) combined with its innovative point-of-sale hearing screening kiosks designed for consumers with mild-to-moderate hearing loss to purchase over-the-counter hearing aids without being seen by a hearing care professional. For more information about the company, visit www.INND.com.

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

BioMedNewsBreaks — Soligenix Inc. (NASDAQ: SNGX) Publishes Positive HyBryte Study Results In Oncology and Therapy 

Soligenix (NASDAQ: SNGX) announced the publication of positive results from its comparability study evaluating HyBryte(TM) versus Valchlor(R) for the treatment…

11 hours ago

BioMedNewsBreaks — NurExone Biologic Inc. (TSX.V: NRX) (OTCQB: NRXBF) (FSE: J90) Wins BOLD Awards VII Healthcare Honor, Engages IBN For Investor Outreach 

This article has been disseminated on behalf of NurExone Biologic and may include paid advertising.  NurExone Biologic (TSX.V: NRX) (OTCQB: NRXBF) (FSE: J90) announced…

11 hours ago

BioMedNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Partners with TechForce Robotics to Advance AI-Enabled GMP Automation Platform

Oncotelic Therapeutics (OTCQB: OTLC) announced a strategic partnership with TechForce Robotics to advance commercialization of…

12 hours ago

BioMedNewsBreaks — LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Files 2025 Form 10-K, Highlights Transformational Year 

LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced it has filed its Annual Report on Form 10-K for the…

1 day ago

BioMedNewsBreaks — HeartBeam Inc.’s (NASDAQ: BEAT) ‘Significant Turning Point’ Spotlighted in Recent Article

HeartBeam (NASDAQ: BEAT) was featured in a recent article that discussed Joseph Gunnar & Co.’s…

2 days ago

BioMedNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Highlights Phase 3 CTCL Progress and Orphan Drug Milestones in 2025 Results

Soligenix (NASDAQ: SNGX) reported 2025 results highlighting progress across its rare disease pipeline, including advancing…

3 days ago